Biosnch.ai
BioSynch AI is an AI-native drug discovery company that turns early drug R&D into an engineering workflow, combining advanced machine-learning models, very large biological datasets, and an integrated wet-lab, to design and advance new medicines faster and with higher odds of success.
Funding
Every round, secondary, debt facility or acquisition involving Biosnch.ai that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in